ArticleSurgical endoscopy2025
Postpancreatectomy acute pancreatitis in pancreaticoduodenectomy and distal pancreatectomy: a retrospective cohort study on risk factors and clinical outcomes.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundPostpancreatectomy acute pancreatitis (PPAP) is a severe complication that can occur following pancreaticoduodenectomy (PD) or distal pancreatectomy (DP). Specific studies focus on the difference of PPAP in PD and DP are lacking.
methodsPatients who underwent PD or DP between 2019 and 2024 were retrospectively reviewed. Perioperative parameters and outcomes were collected. PPAP was defined in accordance with the criteria established by the International Study Group for Pancreatic Surgery (ISGPS).
resultsThe study cohort comprised 1,017 patients undergoing pancreatic resection: 670 PD and 347 DP. Among PD cases, PPAP occurred in 142 patients (21.19%) and was significantly associated with a higher incidence of postoperative pancreatic fistula (POPF) (82.39% vs. 37.12%, P < 0.0001), particularly in cases of grade B and C POPF (P < 0.0001). In DP cases, PPAP occurred in 17.58% of patients. In PD cases, patients with PPAP experienced increased morbidity (P < 0.0001), including a higher incidence of POPF (91.8% vs. 65.38%, P < 0.0001) and grade B POPF (39.34% vs. 11.54%, P < 0.0001). Compared to patients who had PD, those who had DP experienced a lower incidence of postoperative hyperamylasemia (POH) (30.55% vs. 43.88%, P < 0.0001).
conclusionPPAP represents a significant postoperative complication following pancreatic resection. Current evidence suggests associations between PPAP and morbidities in PD and DP cases. Notably, PPAP following DP appears to correlate with less severe clinical consequences compared to PD-associated PPAP.
Indexed as
Identifiers
40389656What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.